PBYI Puma Biotechnology Forecast, Technical & Fundamental Analysis

operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer

Industry Biotechnology

Get AI intraday signals

PBYI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PBYI
(Try 14 days for Free)

View a ticker or compare two or three

Compare

PBYI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PBYI
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

PBYI is expected to report earnings to fall 76.09% to 10 cents per share on February 27

Puma Biotechnology PBYI Stock Earnings Reports

Q4'24

Est.

$0.11

Q3'24

Beat

by $0.13

Q2'24

Est.

$-0.05

Q1'24

Beat

by $0.12

Q4'23

Missed

by $0.04

The last earnings report on November 07 showed earnings per share of 46 cents, beating the estimate of 33 cents. With 120.72K shares outstanding, the current market capitalization sits at 143.34M.

A.I. Advisor

published General Information

General Information

operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

10880 Wilshire Boulevard

Phone

+1 424 248-6500

Employees

185

Web

http://www.pumabiotechnology.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	31.26	1.82	+6.18%
GameStop Corp
TSLA	479.86	16.84	+3.64%
Tesla
AAPL	253.48	2.44	+0.97%
Apple
BTC.X	106140.600000	110.890625	+0.10%
Bitcoin cryptocurrency
SPY	604.29	-2.50	-0.41%
SPDR® S&P 500® ETF Trust

PBYI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PBYI has been loosely correlated with ABCL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PBYI jumps, then ABCL could also see price increases.

Ticker / NAME	Correlation To PBYI	1D Price Change %
PBYI	100%	-2.67%
ABCL - PBYI	35% Loosely correlated	-2.45%
ARVN - PBYI	34% Loosely correlated	+0.58%
AURA - PBYI	34% Loosely correlated	-2.47%
FHTX - PBYI	33% Poorly correlated	N/A
SLRN - PBYI	32% Poorly correlated	+3.86%
More